Skip to content

Previvors Recharge: A Resilience Program for Cancer Previvors

Previvors Recharge: A Resilience Program for Cancer Previvors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06378749
Acronym
PreCharge
Enrollment
138
Registered
2024-04-22
Start date
2024-04-11
Completion date
2024-09-27
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Cancer, Mental Health Issue

Keywords

Resilience, Coping, Previvor, well-being

Brief summary

It is estimated that 1 in 279 people may be carriers of a Hereditary Cancer Syndromes (HCS), a cancer risk that is associated with germline mutations (inherited genetic mutations passed directly from a parent to a child that create a genetic predisposition to certain types of cancer). Individuals with an HCS who have never been diagnosed with cancer (Previvors) have up to an 80% lifetime risk of developing cancer and are at an increased risk of developing multiple primary cancers during their lifetime, often with onset at an early age. Previvors face multiple forms of adversity, including a multitude of annual cancer screenings and the uncertainty of not only their own health but the health of affected family members. This study will examine the acceptability and preliminary effects of PreCharge, a resilience-boosting solution specifically designed for Previvors and delivered primarily via bi-directional text messaging. PreCharge uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose while also proactively addressing scanxiety. Up to 150 Hereditary Cancer Previvors will be recruited for a 30-day pilot test. Participants will complete a baseline assessment, and then be provided with 30 days of access to the PreCharge program. At the end of the 30 days, they will be prompted to complete a follow-up assessment. Outcomes to be examined will include pre-post changes on the Connor Davidson Resilience Scale.

Interventions

BEHAVIORALPreCharge

PreCharge is an intervention for Hereditary Cancer Syndrome Previvors that administers brief assessments and uses multivariate algorithms and tailoring technology to provide timely, individualized, bi-directional text messages to improve resilience and coping. The program uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose. It will also proactively provide access to online tools prior to medical appointments to address scanxiety (e.g., management of emotion tips; mindfulness meditation; communication scripts; breathing exercises). At any time, users will be able to text a trigger word to indicate that they need extra support and will receive just-in-time assistance via text message.

Sponsors

Pro-Change Behavior Systems
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Identified as having Hereditary Cancer Syndrome 2. Never having been diagnosed with cancer 3. Over 18 years of age 4. Living in the United States 5. English speaking 6. Having a score of 26 or below on the Connor Davidson Resilience Scale (10 Item) 7. Access to a mobile phone 8. Agree to receive text messages.

Design outcomes

Primary

MeasureTime frameDescription
Connor Davidson Resilience Scale (CDRISC)Baseline and 1 MonthThis 10-item scale assesses five factors related to resilience. Each item is rated on a 5-point scale with higher scores reflecting greater resilience. Scores range from 0-40. There are well-established norms across a variety of populations and the scale has been used as an outcome measure to evaluate a variety of different intervention programs.

Secondary

MeasureTime frameDescription
Acceptance and Action Questionnaire (AAQII)Baseline and 1 MonthThe Acceptance and Action Questionnaire - version 2 (AAQII), is the most widely used measure of psychological flexibility. Higher total scores on the 7-item scale indicate higher psychological inflexibility, experiential avoidance, and more potential psychological distress. Lower total scores mean more psychological flexibility and normative values are available. Scores range from 7 to 49.

Other

MeasureTime frameDescription
Patient Health Questionnaire-2 (PHQ-2)Baseline and 1 MonthThe PHQ-2 inquires about the frequency of depressed mood, with a score ranging from 0 to 6 and with greater scores indicating higher likelihood of Major Depressive Disorder. The authors identify a cut-off score of 3 as the optimal cut point for screening purposes, and stated that a cut point of 2 would enhance sensitivity. A score of 3 or greater on the PHQ-2 indicates that Major Depressive Disorder is likely and further evaluation is needed to assess for depression. The PHQ-2, comprising the first 2 items of the PHQ-9, inquires about the degree to which an individual has experienced depressed mood and anhedonia over the past two weeks.
Generalized Anxiety Disorder-2 (GAD-2)Baseline and 1 MonthThe Generalized Anxiety Disorder two questions scale (GAD-2) is an ultra brief and easy to perform initial screening tool for Generalized Anxiety Disorder (GAD). The two questions are rated on a zero to three scale for a total score of zero to six with greater scores indicating higher likelihood of Generalized Anxiety Disorder. A score of 3 points is the preferred cut-off for identifying possible cases and in which further diagnostic evaluation for generalized anxiety disorder is warranted.
Cancer Behavior Inventory (CBI-B V2.0-12)Baseline and 1 MonthThe short version of the Cancer Behavior Inventory (CBI-B: 12 items) measures self-efficacy for coping which has been shown to have a positive impact on wellbeing, quality of life, anxiety, and depression in cancer patients, even after treatment. Each item is rated on a 1 to 9 scale for a total score range of 12-108 with higher scores indicating higher levels of confidence.

Countries

United States

Participant flow

Participants by arm

ArmCount
PreCharge Intervention Pilot
After completing the baseline assessment, all pilot participants will have access to the PreCharge pilot program for 30 days. At the end of the 30 day pilot, they will be directed to the follow-up assessment. PreCharge: PreCharge is an intervention for Hereditary Cancer Syndrome Previvors that administers brief assessments and uses multivariate algorithms and tailoring technology to provide timely, individualized, bi-directional text messages to improve resilience and coping. The program uses proven approaches to behavior change tailoring to increase resilience by promoting a positive mindset, strong social connections, and a deep sense of meaning and purpose. It will also proactively provide access to online tools prior to medical appointments to address scanxiety (e.g., management of emotion tips; mindfulness meditation; communication scripts; breathing exercises). At any time, users will be able to text a trigger word to indicate that they need extra support and will receive just-in-time assistance via text message.
134
Total134

Baseline characteristics

CharacteristicPreCharge Intervention Pilot
Age, Continuous41.67 years
STANDARD_DEVIATION 10.06
Race/Ethnicity, Customized
Asian or Pacific Islander
1 Participants
Race/Ethnicity, Customized
Black
7 Participants
Race/Ethnicity, Customized
Hispanic
8 Participants
Race/Ethnicity, Customized
Mixed
4 Participants
Race/Ethnicity, Customized
Other
1 Participants
Race/Ethnicity, Customized
White
113 Participants
Sex: Female, Male
Female
128 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 138
other
Total, other adverse events
0 / 138
serious
Total, serious adverse events
0 / 138

Outcome results

Primary

Connor Davidson Resilience Scale (CDRISC)

This 10-item scale assesses five factors related to resilience. Each item is rated on a 5-point scale with higher scores reflecting greater resilience. Scores range from 0-40. There are well-established norms across a variety of populations and the scale has been used as an outcome measure to evaluate a variety of different intervention programs.

Time frame: Baseline and 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
PreCharge Intervention PilotConnor Davidson Resilience Scale (CDRISC)Baseline22.59 score on a scaleStandard Deviation 4.06
PreCharge Intervention PilotConnor Davidson Resilience Scale (CDRISC)Post Intervention (30 days)23.53 score on a scaleStandard Deviation 4.86
p-value: 0.029t-test, 2 sided
Secondary

Acceptance and Action Questionnaire (AAQII)

The Acceptance and Action Questionnaire - version 2 (AAQII), is the most widely used measure of psychological flexibility. Higher total scores on the 7-item scale indicate higher psychological inflexibility, experiential avoidance, and more potential psychological distress. Lower total scores mean more psychological flexibility and normative values are available. Scores range from 7 to 49.

Time frame: Baseline and 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
PreCharge Intervention PilotAcceptance and Action Questionnaire (AAQII)Baseline27.21 score on a scaleStandard Deviation 6.97
PreCharge Intervention PilotAcceptance and Action Questionnaire (AAQII)Post-Intervention (30 days)25.05 score on a scaleStandard Deviation 7.15
p-value: <0.001t-test, 2 sided
Other Pre-specified

Cancer Behavior Inventory (CBI-B V2.0-12)

The short version of the Cancer Behavior Inventory (CBI-B: 12 items) measures self-efficacy for coping which has been shown to have a positive impact on wellbeing, quality of life, anxiety, and depression in cancer patients, even after treatment. Each item is rated on a 1 to 9 scale for a total score range of 12-108 with higher scores indicating higher levels of confidence.

Time frame: Baseline and 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
PreCharge Intervention PilotCancer Behavior Inventory (CBI-B V2.0-12)Baseline69.16 score on a scaleStandard Deviation 16.04
PreCharge Intervention PilotCancer Behavior Inventory (CBI-B V2.0-12)Post Intervention (30 Days)76.12 score on a scaleStandard Deviation 15.99
p-value: <0.001t-test, 2 sided
Other Pre-specified

Generalized Anxiety Disorder-2 (GAD-2)

The Generalized Anxiety Disorder two questions scale (GAD-2) is an ultra brief and easy to perform initial screening tool for Generalized Anxiety Disorder (GAD). The two questions are rated on a zero to three scale for a total score of zero to six with greater scores indicating higher likelihood of Generalized Anxiety Disorder. A score of 3 points is the preferred cut-off for identifying possible cases and in which further diagnostic evaluation for generalized anxiety disorder is warranted.

Time frame: Baseline and 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
PreCharge Intervention PilotGeneralized Anxiety Disorder-2 (GAD-2)Baseline2.81 score on a scaleStandard Deviation 1.7
PreCharge Intervention PilotGeneralized Anxiety Disorder-2 (GAD-2)Post Intervention (30 days)2.16 score on a scaleStandard Deviation 1.58
p-value: <0.001t-test, 2 sided
Other Pre-specified

Patient Health Questionnaire-2 (PHQ-2)

The PHQ-2 inquires about the frequency of depressed mood, with a score ranging from 0 to 6 and with greater scores indicating higher likelihood of Major Depressive Disorder. The authors identify a cut-off score of 3 as the optimal cut point for screening purposes, and stated that a cut point of 2 would enhance sensitivity. A score of 3 or greater on the PHQ-2 indicates that Major Depressive Disorder is likely and further evaluation is needed to assess for depression. The PHQ-2, comprising the first 2 items of the PHQ-9, inquires about the degree to which an individual has experienced depressed mood and anhedonia over the past two weeks.

Time frame: Baseline and 1 Month

ArmMeasureGroupValue (MEAN)Dispersion
PreCharge Intervention PilotPatient Health Questionnaire-2 (PHQ-2)Baseline1.79 score on a scaleStandard Deviation 1.55
PreCharge Intervention PilotPatient Health Questionnaire-2 (PHQ-2)Post Intervention (30 days)1.26 score on a scaleStandard Deviation 1.45
p-value: <0.001t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026